Gemelli Biotech’s Triosmart® 3-Gas Breath Test and IBS-Smart® Blood Test Featured at DDW 2026
Gemelli Biotech’s diagnostic technologies, including the Trio-Smart® 3-Gas Breath Test and IBS-Smart® Blood Test, will be featured in numerous research presentations at DDW 2026, highlighting their role in gastrointestinal diagnostics. The Trio-Smart® test is notable for detecting hydrogen sulfide alongside hydrogen and methane, which is a unique offering in breath testing.
RALEIGH, N.C.–(BUSINESS WIRE)–Gemelli Biotech announced today that its diagnostic technologies will be featured across multiple research presentations at DDW 2026, the world’s premier gathering of gastrointestinal researchers and clinicians. These studies included the use of Trio-Smart®, a diagnostic 3-gas breath test developed and distributed by Gemelli Biotech that uniquely detects hydrogen sulfide, in addition to hydrogen and methane. Comprehensive 3-gas breath testing is exclusively avail